altRx vs Ro
altRx and Ro both offer brand-name GLP-1 — but they approach it from opposite directions. altRx leads with cheap compounded options ($89 semaglutide) and adds brand on top; Ro is a branded-first, insurance-coordinated platform with a long track record. The deciding variable, again, is your insurance.
Last reviewed 2026-09-01 · Pricing is provider-reported and changes often — confirm current rates on each provider's site. We may earn a commission.
Educational, not medical advice. This page explains GLP-1 medications in general terms. Only a licensed clinician who knows your history can decide what's right for you.
For cash payers, altRx's low compounded pricing wins; Ro only pulls ahead if you have solid GLP-1 insurance coverage.
View Plan: altRxChoose altRx if…
you want the lowest cash price with the flexibility of brand-name if you need it.
Choose Ro if…
you have GLP-1 coverage and want an established, insurance-first branded platform.
Cost breakdown
The numbers that actually decide it, side by side.
| | |
|---|---|---|
| Entry price (cash) | $89/mo (compounded) | Insurance copay, or ~$1,000+ cash |
| Brand-name access | Yes (Wegovy, Zepbound) | Yes (Wegovy, Zepbound, Ozempic, Mounjaro) |
| Financing | Buy Now, Pay Later | — |
| Insurance help | Cash-focused | Insurance + prior-auth navigation |
| ~6-month cost, no insurance | ~$534 (compounded semaglutide) | Potentially $6,000+ at branded cash |
altRx's compounded entry at $89/mo is the anchor: for a cash payer, that's dramatically less than branded GLP-1's ~$1,000+/month list that Ro works within. Even altRx's brand-name options benefit from its financing.
Ro's value proposition isn't a low cash price — it's coverage. If your insurance pays for GLP-1, Ro's job is to get you the branded drug for a copay and handle the prior-authorization paperwork, which can make it cheaper than any cash compounder and gets you an FDA-approved product. Without coverage, that advantage evaporates.
So the honest framing: altRx wins decisively for cash payers and people who want a compounded-or-brand choice in one place; Ro wins for insured patients who want branded medication and don't want to manage the insurance fight themselves.
Full specs, side by side
| | |
|---|---|---|
| Starting price | $89/mo (compounded semaglutide) | Membership + medication (insurance-dependent) |
| Compounded semaglutide | $89/mo (compounded) | Brand Wegovy / Ozempic (price depends on insurance) |
| Tirzepatide | From $149/mo (compounded GLP-1 + GIP) | Brand Zepbound / Mounjaro (price depends on insurance) |
| GLP-1 + GIP option | Yes — compounded tirzepatide (GLP-1 + GIP) from $149/mo | Yes — brand tirzepatide (Zepbound/Mounjaro) |
| Offering type | Both | Branded |
| New-patient offer | Buy Now, Pay Later financing available | Varies by promotion |
| Billing model | Monthly plans; multi-month options | Membership plus medication cost |
| What's included | Online medical evaluation, Medication, Shipping, Dose adjustments | Clinician review, Ongoing support, Insurance navigation |
| Lab work | Online intake; labs may be requested for some patients | May be required depending on plan |
| Shipping | Included | Via partner/retail pharmacy |
| Refills | Monthly refills | Per prescription |
| States | Most US states | Nationwide |
| Pharmacy | US compounding pharmacies (503A); brand via licensed pharmacies | Licensed retail/mail pharmacies (FDA-approved branded drugs) |
| Clinicians | US-licensed prescribers | US-licensed clinicians |
| Insurance | Cash; Buy Now, Pay Later available | Works with insurance |
| Consultation | Asynchronous online medical intake | Clinician-reviewed treatment plan |
| Our rating | 9.6 · Excellent | 9.5 · Excellent |
Medications & formulations
- altRx spans compounded semaglutide/tirzepatide and brand-name Wegovy/Zepbound.
- Ro focuses on the branded, FDA-approved GLP-1 line and is built to maximize insurance-covered access to them.
New to the drugs themselves? Read our plain-language guides to semaglutide and tirzepatide.
Pros & cons
Pros
- Lowest published compounded entry price in our list
- Rare option to choose compounded OR brand-name in one place
- Buy Now, Pay Later spreads the cost
- No insurance needed to start
Cons
- Compounded products aren't FDA-approved finished drugs
- Brand-name pricing depends on insurance/eligibility
Pros
- Access to FDA-approved branded GLP-1 (Wegovy, Zepbound, Ozempic, Mounjaro)
- Insurance coordination and prior-auth help
- Large, established telehealth platform
- Clinician review on every plan
Cons
- Can be expensive without insurance coverage
- Membership fee on top of medication
- Branded supply can be affected by shortages
Where each one has the edge
We don't tally a winner — that hides the trade-offs. Here's who leads on each dimension and why.
altRx's compounded entry from $89/mo undercuts branded cash pricing.
Ro is purpose-built around insurance coverage.
Ro is a large, well-known telehealth platform.
altRx offers Buy Now, Pay Later.
Both offer branded GLP-1; altRx adds compounded options.
Match by your priority
The fastest way to decide: find your top priority, see which program we'd point you to.
If your priority is You're paying cash
If your priority is You have GLP-1 insurance coverage
If your priority is You want a big, established brand
If your priority is You want maximum medication flexibility
altRx vs Ro: common questions
The bottom line
Coverage is the deciding factor. With GLP-1 insurance, Ro shines and gets you an FDA-approved product. Paying out of pocket, altRx's compounded pricing (with a brand option in reserve) is the value play.
How we compare — and how to read this
We compare programs on the factors that actually affect a patient: real price (including whether it's compounded or branded), medications and formulations offered, shipping, pharmacy accreditation and clinician model, insurance stance, and commitment. We name a top pick for most people, but we show the trade-offs in full so you can override it when your priorities or insurance point the other way. Pricing is provider-reported and changes frequently — and compounded-drug availability shifts with FDA shortage status — so always confirm the current details on the provider's own site before enrolling. Affiliate relationships do not change a program's placement. This page is educational and not medical advice; see our disclaimer.